Key terms
About PLX
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PLX news
No recent news articles are available for PLX
No recent press releases are available for PLX
PLX Financials
Key terms
Ad Feedback
PLX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PLX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
